Jamie Vanhecker

发表

APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

H. Sanchez, D. Andes, K. Marchillo, 2019, Antimicrobial Agents and Chemotherapy.

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

D. Andes, K. Marchillo, P. Ambrose, 2018, Antimicrobial Agents and Chemotherapy.

Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus

D. Andes, K. Marchillo, A. Lepak, 2013, Antimicrobial Agents and Chemotherapy.

Isavuconazole Pharmacodynamic Target Determination for Candida Species in an In Vivo Murine Disseminated Candidiasis Model

D. Andes, D. Diekema, K. Marchillo, 2013, Antimicrobial Agents and Chemotherapy.

In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model

D. Andes, K. Marchillo, A. Lepak, 2015, Antimicrobial Agents and Chemotherapy.

In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model

D. Andes, K. Marchillo, A. Lepak, 2018, Antimicrobial Agents and Chemotherapy.

In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model

D. Andes, K. Marchillo, A. Lepak, 2017, Antimicrobial Agents and Chemotherapy.

Impact of In Vivo Triazole and Echinocandin Combination Therapy for Invasive Pulmonary Aspergillosis: Enhanced Efficacy against Cyp51 Mutant Isolates

D. Andes, K. Marchillo, A. Lepak, 2013, Antimicrobial Agents and Chemotherapy.

Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target

D. Andes, K. Marchillo, A. Lepak, 2015, Antimicrobial Agents and Chemotherapy.

Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus

D. Andes, K. Marchillo, A. Lepak, 2013, Antimicrobial Agents and Chemotherapy.